*1.Please list your first name, last name, and email:(Required.)

First name:

Last name:

Email:

*2.What is your specialty?(Required.)

*3.How many patients with metastatic gastric cancer do you treat each week?(Required.)

1 to 10

11 to 25

26 to 50

I am not directly involved in patient care

*4.The following biomarkers are actionable in advanced esophagogastric cancer except:(Required.)

dMMR

HER2 mutation

EGFR amplification

PDL1 overexpression

*5.The addition of immunotherapy to chemotherapy in the 1st line Rx of advanced esophagogastric cancer significantly improves PFS and OS irrespective of PDL1 CPS:(Required.)

True

False